Results
|
341.
|
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. [electronic resource] by
- Boner, G
- Cooper, M E
- McCarroll, K
- Brenner, B M
- de Zeeuw, D
- Kowey, P R
- Shahinfar, S
- Dickson, T
- Crow, R S
- Parving, H-H
Producer: 20051220
In:
Diabetologia vol. 48
Availability: No items available.
|
|
342.
|
|
|
343.
|
|
|
344.
|
Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines. [electronic resource] by
- Ziai, F
- Nagano, H
- Kusaka, M
- Coito, A J
- Troy, J L
- Nadeau, K C
- Rennke, H G
- Tilney, N L
- Brenner, B M
- MacKenzie, H S
Producer: 20000824
In:
Kidney international vol. 57
Availability: No items available.
|
|
345.
|
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. [electronic resource] by
- Brenner, B M
- Cooper, M E
- de Zeeuw, D
- Keane, W F
- Mitch, W E
- Parving, H H
- Remuzzi, G
- Snapinn, S M
- Zhang, Z
- Shahinfar, S
Producer: 20010927
In:
The New England journal of medicine vol. 345
Availability: No items available.
|
|
346.
|
|
|
347.
|
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]. [electronic resource] by
- Parving, H H
- Brenner, B M
- Cooper, M E
- de Zeeuw, D
- Keane, W F
- Mitch, W E
- Remuzzi, G
- Snapinn, S M
- Zhang, Z
- Shahinfar, S
Producer: 20011101
In:
Ugeskrift for laeger vol. 163
Availability: No items available.
|
|
348.
|
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial. [electronic resource] by
- Heerspink, H J L
- Ninomiya, T
- Persson, F
- Brenner, B M
- Brunel, P
- Chaturvedi, N
- Desai, A S
- Haffner, S M
- Mcmurray, J J V
- Solomon, S D
- Pfeffer, M A
- Parving, H-H
- de Zeeuw, D
Producer: 20161031
In:
Diabetes, obesity & metabolism vol. 18
Availability: No items available.
|
|
349.
|
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. [electronic resource] by
- Jafar, T H
- Schmid, C H
- Landa, M
- Giatras, I
- Toto, R
- Remuzzi, G
- Maschio, G
- Brenner, B M
- Kamper, A
- Zucchelli, P
- Becker, G
- Himmelmann, A
- Bannister, K
- Landais, P
- Shahinfar, S
- de Jong, P E
- de Zeeuw, D
- Lau, J
- Levey, A S
Producer: 20010726
In:
Annals of internal medicine vol. 135
Availability: No items available.
|
|
350.
|
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). [electronic resource] by
- Brenner, B M
- Cooper, M E
- de Zeeuw, D
- Grunfeld, J P
- Keane, W F
- Kurokawa, K
- McGill, J B
- Mitch, W E
- Parving, H H
- Remuzzi, G
- Ribeiro, A B
- Schluchter, M D
- Snavely, D
- Zhang, Z
- Simpson, R
- Ramjit, D
- Shahinfar, S
Producer: 20020606
In:
Journal of the renin-angiotensin-aldosterone system : JRAAS vol. 1
Availability: No items available.
|
|
351.
|
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. [electronic resource] by
- Anderson, G R
- Brenner, B M
- Swede, H
- Chen, N
- Henry, W M
- Conroy, J M
- Karpenko, M J
- Issa, J P
- Bartos, J D
- Brunelle, J K
- Jahreis, G P
- Kahlenberg, M S
- Basik, M
- Sait, S
- Rodriguez-Bigas, M A
- Nowak, N J
- Petrelli, N J
- Shows, T B
- Stoler, D L
Producer: 20011212
In:
Cancer research vol. 61
Availability: No items available.
|